138 related articles for article (PubMed ID: 35831241)
1. Treatment of melasma with platelet-rich plasma: A self-controlled clinical trial.
González-Ojeda A; Cervantes-Guevara G; Chejfec-Ciociano JM; Cervantes-Cardona GA; Acevedo-Guzman D; Puebla-Mora AG; Cortés-Lares JA; Chávez-Tostado M; Álvarez-Villaseñor AS; Cervantes-Pérez E; Ramos-Álvarez MP; Pacheco-Vallejo LR; Barbosa-Camacho FJ; Fuentes-Orozco C
Dermatol Ther; 2022 Sep; 35(9):e15703. PubMed ID: 35831241
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of platelet-rich plasma efficacy in melasma.
Acar A; Ozturk A; Sokmen N; Unal I; Ertam Sagduyu I
J Cosmet Laser Ther; 2022 Jul; 24(1-5):36-39. PubMed ID: 35852165
[TBL] [Abstract][Full Text] [Related]
3. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
Tekam PS; Belgaumkar VA
Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
[TBL] [Abstract][Full Text] [Related]
4. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma.
Mumtaz M; Chandio TH; Shahzad MK; Hanif N; Anwar S; Rafique S
J Coll Physicians Surg Pak; 2021 May; 31(5):502-505. PubMed ID: 34027858
[TBL] [Abstract][Full Text] [Related]
6. Platelet-rich plasma is a useful therapeutic option in melasma.
Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
[No Abstract] [Full Text] [Related]
7. Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma.
Sarkar R; Ghunawat S; Narang I; Verma S; Garg VK; Dua R
J Cosmet Dermatol; 2019 Aug; 18(4):1066-1073. PubMed ID: 31033184
[TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
Patil NK; Bubna AK
Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
[TBL] [Abstract][Full Text] [Related]
9. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
Adel S; Serri A; Abd El-Raheem T
Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
[TBL] [Abstract][Full Text] [Related]
10. Platelet-rich plasma treatment for melasma: A pilot study.
Sirithanabadeekul P; Dannarongchai A; Suwanchinda A
J Cosmet Dermatol; 2020 Jun; 19(6):1321-1327. PubMed ID: 31568636
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with quality of life in facial melasma: a cross-sectional study.
Pollo CF; Miot LDB; Meneguin S; Miot HA
Int J Cosmet Sci; 2018 May; ():. PubMed ID: 29734511
[TBL] [Abstract][Full Text] [Related]
12. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
Adalatkhah H; Sadeghi-Bazargani H
Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of melasma in patients before and after treatment based on lipomics.
Zhu Y; Xu J; Song X; Xiang W
Lipids Health Dis; 2024 May; 23(1):138. PubMed ID: 38734619
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis.
Zhu Y; Zeng X; Ying J; Cai Y; Qiu Y; Xiang W
PLoS One; 2022; 17(1):e0262833. PubMed ID: 35085327
[TBL] [Abstract][Full Text] [Related]
15. Is There a Correlation between Severity of Melasma and Quality of Life?
Jusuf NK; Putra IB; Mahdalena M
Open Access Maced J Med Sci; 2019 Aug; 7(16):2615-2618. PubMed ID: 31777617
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.
Lima EVA; Lima MMDA; Paixão MP; Miot HA
BMC Dermatol; 2017 Nov; 17(1):14. PubMed ID: 29183309
[TBL] [Abstract][Full Text] [Related]
17. Autologous intralesional platelet rich plasma improves melasma.
Tuknayat A; Thami GP; Bhalla M; Sandhu JK
Dermatol Ther; 2021 Mar; 34(2):e14881. PubMed ID: 33591615
[TBL] [Abstract][Full Text] [Related]
18. Platelet-Rich Plasma in Melasma-A Systematic Review.
Sarkar R; Gupta M
Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
[TBL] [Abstract][Full Text] [Related]
19. Split-face comparison of hydroquinone 4% plus nitrogen plasma vs. hydroquinone 4% alone in the treatment of melasma.
Yousefi M; Hadian K; Babossalam S; Diab R; Akhlaghi M; Aghighi M; Abdollahimajd F; Shokri B
Lasers Med Sci; 2023 Apr; 38(1):113. PubMed ID: 37103690
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of 25% L-ascorbic acid (C'ensil) in the treatment of melasma.
Hwang SW; Oh DJ; Lee D; Kim JW; Park SW
J Cutan Med Surg; 2009; 13(2):74-81. PubMed ID: 19298775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
